| 000 | 01400 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515095804.0 | ||
| 264 | 0 | _c20080219 | |
| 008 | 200802s 0 0 eng d | ||
| 022 | _a1092-1095 | ||
| 024 | 7 |
_a10.1188/07.CJON.847-851 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWiley, Kathleen E | |
| 245 | 0 | 0 |
_aMultiple myeloma and treatment-related thromboembolism: oncology nurses' role in prevention, assessment, and diagnosis. _h[electronic resource] |
| 260 |
_bClinical journal of oncology nursing _cDec 2007 |
||
| 300 |
_a847-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDrug Monitoring _xnursing |
| 650 | 0 | 4 | _aEarly Diagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aLenalidomide |
| 650 | 0 | 4 |
_aMultiple Myeloma _xcomplications |
| 650 | 0 | 4 | _aNurse's Role |
| 650 | 0 | 4 | _aNursing Assessment |
| 650 | 0 | 4 |
_aOncology Nursing _xorganization & administration |
| 650 | 0 | 4 | _aPatient Compliance |
| 650 | 0 | 4 | _aPrimary Prevention |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThalidomide _xadverse effects |
| 650 | 0 | 4 |
_aThromboembolism _xchemically induced |
| 773 | 0 |
_tClinical journal of oncology nursing _gvol. 11 _gno. 6 _gp. 847-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1188/07.CJON.847-851 _zAvailable from publisher's website |
| 999 |
_c17577574 _d17577574 |
||